Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan Pantziarka

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Acta Oncologica (Stockholm, Sweden)|August 2, 2021
Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in NorwayNathalie C Støer, Gauthier Bouche, Pan Pantziarka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2022
Drug repurposing as a potential source of innovative therapies in cervical cancerRica Capistrano I, Sonz Paul, Ingrid Boere, et al.
Frontiers in Oncology|September 28, 2020
Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)Albrecht Reichle, Daniel Heudobler, Christopher Gerner, et al.
Cancers|February 11, 2023
Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing CandidatesElizabeth Ann Roundhill, Pan Pantziarka, Danielle E Liddle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2024
How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcomaSilvia Stacchiotti, Gauthier Bouche, Ralf Herold, et al.
Frontiers in Oncology|March 12, 2024
The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatmentsDenise Robinson, Hugh Leonard, Giacomo Giulio Baldi, et al.
Frontiers in Oncology|July 11, 2022
Drug Repurposing by Tumor Tissue EditingFlorian Lüke, Dennis Christoph Harrer, Pan Pantziarka, et al.
Ecancermedicalscience|December 12, 2017
Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agentsCiska Verbaanderd, Hannelore Maes, Marco B Schaaf, et al.
Frontiers in Oncology|January 11, 2020
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis InductionDaniel Heudobler, Florian Lüke, Martin Vogelhuber, et al.
Ecancermedicalscience|January 26, 2019
ReDO_DB: the repurposing drugs in oncology databasePan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Acta Oncologica (Stockholm, Sweden)|August 2, 2021
Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in NorwayNathalie C Støer, Gauthier Bouche, Pan Pantziarka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2022
Drug repurposing as a potential source of innovative therapies in cervical cancerRica Capistrano I, Sonz Paul, Ingrid Boere, et al.
Frontiers in Oncology|September 28, 2020
Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)Albrecht Reichle, Daniel Heudobler, Christopher Gerner, et al.
Cancers|February 11, 2023
Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing CandidatesElizabeth Ann Roundhill, Pan Pantziarka, Danielle E Liddle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 13, 2024
How to develop new systemic treatments in ultra-rare cancers with high unmet needs? The case of alveolar soft-part sarcomaSilvia Stacchiotti, Gauthier Bouche, Ralf Herold, et al.
Frontiers in Oncology|March 12, 2024
The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatmentsDenise Robinson, Hugh Leonard, Giacomo Giulio Baldi, et al.
Frontiers in Oncology|July 11, 2022
Drug Repurposing by Tumor Tissue EditingFlorian Lüke, Dennis Christoph Harrer, Pan Pantziarka, et al.
Ecancermedicalscience|December 12, 2017
Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agentsCiska Verbaanderd, Hannelore Maes, Marco B Schaaf, et al.
Frontiers in Oncology|January 11, 2020
Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue-Going Beyond Apoptosis InductionDaniel Heudobler, Florian Lüke, Martin Vogelhuber, et al.
Ecancermedicalscience|January 26, 2019
ReDO_DB: the repurposing drugs in oncology databasePan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, et al.
Pageof 6